POEMS Syndrome: A Patient Guide

POEMS syndrome is an exceptionally rare and complex condition that often takes a long time to identify because it mimics more common nerve disorders. At its core, POEMS is a paraneoplastic syndrome, a disorder where the body’s immune system or signaling pathways overreact to a small population of abnormal cells ^[1]. In this case, a group of abnormal plasma cells in the bone marrow—the cells that usually protect you by making antibodies—begins to trigger a complex inflammatory response. While POEMS shares some features with multiple myeloma, these abnormal cells typically do not grow into large, bone-destroying tumors ^[2]. Instead, they prompt the release of inflammatory signals, prominently including a protein called VEGF (Vascular Endothelial Growth Factor) ^[3].

This surge of VEGF and other inflammatory mediators makes your blood vessels “leaky” and causes damage across multiple systems in your body ^[4]. This multisystem impact is captured in the name POEMS, which stands for Polyneuropathy (nerve damage), Organomegaly (enlarged organs), Endocrinopathy (hormone imbalances), Monoclonal protein (the abnormal protein from the plasma cells), and Skin changes ^[5]. Most patients experience a progressive weakening and numbness in their hands and feet, alongside fluid build-up, skin thickening, or changes in their hormone levels ^[6][7].

Because the blood vessels are inflamed and other factors are at play, patients have a high risk of developing blood clots early in the disease. Cohort studies have shown that approximately 30% of patients experience a clotting event, such as a stroke or deep vein thrombosis, often before they have even started formal treatment ^[8][9]. Recognizing the warning signs of these events is a vital part of staying safe while your care team works to stabilize the condition. Do not start taking aspirin or anticoagulants on your own, as your doctor will create an individualized clot-prevention plan based on your specific risk factors ^[10].

The path forward focuses on attacking the source of the problem—the abnormal plasma cells—rather than just managing the symptoms. Depending on how widespread the disease is, this may involve targeted radiation, high-dose chemotherapy with a stem cell transplant, or other systemic medications ^[11][12]. While the damage to the nerves can be severe, the outlook for many patients is one of hope and recovery. When the inflammatory response is stopped, the body can begin to heal, and many people experience a significant return of strength and function over the months and years following treatment ^[13].